Executive Vice President
Molecular Biology
Aduro Biotech
Netherlands
Dirk G. Brockstedt, Ph.D., joined Aduro in April 2009 and has served as our Senior Vice President of Research and Development since September 2011. Prior to joining Aduro, Dr. Brockstedt held various positions of increasing responsibility in the immunotherapy group at Cerus Corporation, culminating as Director of Immunology. Earlier in his career, Dr. Brockstedt worked as a scientist at Aventis in the Immunotherapy and Anti-Angiogenesis group from 1999 until 2002, focused on developing novel anti-cancer therapies. He has co-authored 40 scientific papers and is a named inventor on five issued patents and several pending applications. Dr. Brockstedt holds a Diploma/Masters of Science in Microbiology from the University of Kiel and earned his Ph.D. from the University of Kiel and Stanford University, the latter at which he served as a post-doctoral fellow at the Stanford School of Medicine in the department of Pathology.
Immunotherapy and Anti-Angiogenesis